Varian, an American radiation oncology treatments and software maker, completed the acquisition of Endocare and Alicon, two cancer care solutions providers, for $185m. These acquisitions provide Varian with a leading position in the high-value interventional oncology segment, which is expected to grow from approximately $860m in 2019 to over $1bn in 2022.